JMFC
J.M. Forbes & Co Portfolio holdings
AUM
$1.09B
This Quarter Return
+5.94%
1 Year Return
+21.04%
3 Year Return
+89.06%
5 Year Return
+134.53%
10 Year Return
+347.81%
AUM
$1.02B
AUM Growth
+$1.02B
(+4.9%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
40.79%
Holding
139
New
6
Increased
37
Reduced
54
Closed
1
Top Buys
| 1 |
Broadcom
AVGO
|
$17.6M |
| 2 |
Ginkgo Bioworks
DNA
|
$1.02M |
| 3 |
Cincinnati Financial
CINF
|
$293K |
| 4 |
iShares MSCI KLD 400 Social ETF
DSI
|
$290K |
| 5 |
Lockheed Martin
LMT
|
$248K |
Top Sells
| 1 |
Microsoft
MSFT
|
$613K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$390K |
| 3 |
Zoetis
ZTS
|
$306K |
| 4 |
PepsiCo
PEP
|
$298K |
| 5 |
Visa
V
|
$291K |
Sector Composition
| 1 | Technology | 26.54% |
| 2 | Financials | 9.19% |
| 3 | Healthcare | 9.01% |
| 4 | Consumer Staples | 7.26% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
State Street
STT
$32.6B
| $452K | 0.04% | 5,112 +77 | +2% | +$6.81K |
|
102
Yum! Brands
YUM
$40.8B
| $452K | 0.04% | 3,235 -147 | -4% | -$20.5K |
|
103
DuPont de Nemours
DD
$32.2B
| $445K | 0.04% | 4,991 | – | – |
|
104
Bristol-Myers Squibb
BMY
$96B
| $415K | 0.04% | 8,027 -1,228 | -13% | -$63.5K |
|
105
3M
MMM
$82.8B
| $415K | 0.04% | 3,038 | – | – |
|
106
Genuine Parts
GPC
$19.4B
| $400K | 0.04% | 2,865 -85 | -3% | -$11.9K |
|
107
Starbucks
SBUX
$100B
| $396K | 0.04% | 4,058 +306 | +8% | +$29.8K |
|
108
Paychex
PAYX
$50.2B
| $387K | 0.04% | 2,884 | – | – |
|
109
Target
TGT
$43.6B
| $385K | 0.04% | 2,472 | – | – |
|
110
Boeing
BA
$177B
| $370K | 0.04% | 2,436 | – | – |
|
111
Edwards Lifesciences
EW
$47.8B
| $370K | 0.04% | 5,610 +325 | +6% | +$21.4K |
|
112
Oracle
ORCL
$635B
| $368K | 0.04% | 2,158 +532 | +33% | +$90.7K |
|
113
Biogen
BIIB
$19.4B
| $362K | 0.04% | 1,869 | – | – |
|
114
Axsome Therapeutics
AXSM
$6.05B
| $345K | 0.03% | 3,840 | – | – |
|
115
Roper Technologies
ROP
$56.6B
| $343K | 0.03% | 617 +62 | +11% | +$34.5K |
|
116
Scotiabank
BNS
$77.6B
| $327K | 0.03% | 6,000 | – | – |
|
117
Intuitive Surgical
ISRG
$170B
| $308K | 0.03% | 627 +72 | +13% | +$35.4K |
|
118
GE Aerospace
GE
$292B
| $307K | 0.03% | 1,629 +4 | +0.2% | +$754 |
|
119
Nuvectis Pharma
NVCT
$167M
| $304K | 0.03% | 48,401 +982 | +2% | +$6.18K |
|
120
Corteva
CTVA
$50.4B
| $300K | 0.03% | 5,110 +127 | +3% | +$7.47K |
|
121
Otis Worldwide
OTIS
$33.9B
| $297K | 0.03% | 2,856 | – | – |
|
122
S&P Global
SPGI
$167B
| $294K | 0.03% | 569 | – | – |
|
|
123
Cincinnati Financial
CINF
$24B
| $293K | 0.03% | +2,156 | New | +$293K |
|
124
iShares 7-10 Year Treasury Bond ETF
IEF
$35.7B
| $289K | 0.03% | 2,941 -51 | -2% | -$5K |
|
125
Qualcomm
QCOM
$173B
| $286K | 0.03% | 1,680 | – | – |
|